United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Healthcare Industry News Trellus Health signs CRO contract to boost clinical trial recruitment, TRLS shares gain 7.7% on AIM Trellus Health signs global CRO contract for TrialSet platform; TRLS stock rises 7.7%. Read more about its clinical trials strategy and cash runway outlook. bySrinathOctober 22, 2025